Pls find enclosed Written Transcript of Earnings Call held on 5th May 2026.
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Ajanta Pharma has disclosed the availability of a written transcript from their earnings call held on 5th May 2026. The filing is made pursuant to Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations 2015. The actual transcript content is not included in this filing but is available on the company's website. The earnings call took place at 4:30 PM on 5th May 2026. This is a standard regulatory disclosure informing stock exchanges and investors where they can access the full transcript. The filing was signed by Gaurang Shah, Sr. VP - Legal & Company Secretary.
This filing is administrative in nature and does not contain new material information. It simply makes the earnings call transcript accessible to investors who wish to review management's commentary in detail. The stock impact will depend on the actual content of the transcript rather than this disclosure.